Evidence map›Paper›PMID 41089730›Full record

ArticleData in brief2025

Data-driven analysis of photocatalytic degradation of pararosaniline using green synthesized SrO nanoparticles.

Neelam Patil Radhika, Malini S, Shobha G, Kalyan Raj, Shylaja K R, Abhishek Appaji

Abstract read
In one paragraph

Article in Data in brief, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Neelam Patil RadhikaDepartment of Chemistry, K S Institute of Technology, Bengaluru, India.
Malini SDepartment of Chemistry, B.M.S. College of Engineering, Bengaluru, India.
Shobha GDepartment of Applied science and Humanities, K S Institute of technology, Bengaluru, India.
Kalyan RajDepartment of Chemistry, B.M.S. College of Engineering, Bengaluru, India.
Shylaja K RDepartment of Chemistry, K S Institute of Technology, Bengaluru, India.
Abhishek AppajiDepartment of Medical Electronics Engineering, B.M.S. College of Engineering, Bengaluru, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pararosaniline is an extensively used carcinogenic dye whose presence in waterbodies poses serious health risk and hence its photocatalytic degradation is an environmentally relevant dataset. The data reported here highlights the synthesis, characterization and kinetics involved in photocatalytic behaviour of SrO during the degradation of cationic triarylmethane dye pararosaniline. SrO nanoparticles were synthesized by using Plant extract as green fuel from Leucas Aspera and characterized by X-ray diffractometers (XRD), Field emission scanning electron microscopes (FESEM), Fourier transform infrared (FTIR), and UV/vis spectrometer. XRD confirmed the crystalline character of SrO matching with JCPDS database card no. 06-520, FESEM shows the presence of nano-rod like structure with rounded edges having average particle size between 23.20nm-95 nm and FTIR confirming the stretching and bending vibrations of Sr-O bond. The Degradation of pararosaniline was spectrophotometrically examined in the presence of sun light by varying catalyst concentration, dye dosage and pH within 60 min. The highest degradation efficiency 89 % of Pararosaniline was obtained at pH=12 with concentration of catalyst 50 mg and concentration of dye 10 ppm. These findings show the potential application of synthesized SrO nanoparticles for environmental remediation.

Indexed as

Green synthesisLeucas asperaPararosanilinePhotocatalytic degradationStrontium oxide nanoparticles

Identifiers

PMID41089730
PMCPMC12516531

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.